A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the Elderly
Public ClinicalTrials.gov record NCT00953524. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Immunogenicity and Safety of Multiple Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adult and Elderly Subjects
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate different doses of the Influenza A/H1N1 pandemic vaccine. Primary Objectives: * To describe the immunogenicity of the candidate vaccines after each injection. * To describe the safety of the candidate vaccines after each injection.
Study identification
- NCT ID
- NCT00953524
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 849 participants
Conditions and interventions
Conditions
Interventions
- Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA) Biological
- Monovalent Subvirion A/H1N1 Influenza vaccine (15 µg of HA) Biological
- Monovalent Subvirion A/H1N1 Influenza vaccine (30 µg of HA) Biological
- Normal saline solution (placebo) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2009 (Type not available)
- Primary completion
- Mar 2010 (Actual)
- Completion
- Dec 2010 (Actual)
- Last update posted
- Mar 10, 2014
2009 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Hoover | Alabama | 35216 | — |
| Not listed | Chandler | Arizona | 85224 | — |
| Not listed | Phoenix | Arizona | 85020 | — |
| Not listed | Anaheim | California | — | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Maddisonville | Kentucky | 42431 | — |
| Not listed | Springfield | Missouri | 65802 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Cincinnati | Ohio | 45227 | — |
| Not listed | Cleveland | Ohio | 44122 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Knoxville | Tennessee | 37920 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Salt Lake City | Utah | 84124 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00953524, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2014 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00953524 live on ClinicalTrials.gov.